Administration of antioxidants in cancer: debate of the decade.
Drug Discov Today
; 23(4): 763-770, 2018 Apr.
Article
em En
| MEDLINE
| ID: mdl-29317341
ABSTRACT
Several randomized clinical trials have divulged that administration of antioxidants during chemotherapy decreases the effectiveness of treatment. Hence, the characteristic feature of this article is extensive assessment of putative benefits and potential risks of natural and synthetic antioxidant supplementation, administered with chemotherapy, based upon the available preclinical and clinical data. After analyzing mixed results, it was concluded that current FDA guidelines should be followed before supplementing antioxidants during cytotoxic treatment. Nevertheless, contradictory experimental animal models opposing human clinical trials discourage the concurrent administration of antioxidants ostensibly owing to the possibility of tumor protection and reduced survival.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias
/
Antioxidantes
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article